Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways
Cancer Reports · 2024-09 · 7 (9)
DOI: 10.1002/cnr2.70006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, online erschienen am 05.09.2024. Verfasst von Jianxin Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Mitochondria, Neoplasms, Terpenes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hebei Province Traditional Chinese Medicine Scientific Research Subjects Programme, Science Research Project of Hebei Education Department.
Abstract (Originalsprache)
Background
In recent decades, natural compounds have been considered a significant source of new antitumor medicines due to their unique advantages. Several in vitro and in vivo studies have focused on the effect of terpenoids on apoptosis mediated by mitochondria in malignant cells. Recent findings In this review article, we focused on six extensively studied terpenoids, including sesquiterpenes (dihydroartemisinin and parthenolide), diterpenes (oridonin and triptolide), and triterpenes (betulinic acid and oleanolic acid), and their efficacy in targeting mitochondria to induce cell death. Terpenoid‐induced mitochondria‐related cell death includes apoptosis, pyroptosis, necroptosis, ferroptosis, autophagy, and necrosis caused by mitochondrial permeability transition. Apoptosis and autophagy interact in meaningful ways. In addition, in view of several disadvantages of terpenoids, such as low stability and bioavailability, advances in research on combination chemotherapy and chemical modification were surveyed.
Conclusion
This article deepens our understanding of the association between terpenoids and mitochondrial cell death, presenting a hypothetical basis for the use of terpenoids in anticancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, China.
- The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Jianxin Guo
Förderung
- National Natural Science Foundation of China
- Hebei Province Traditional Chinese Medicine Scientific Research Subjects Programme
- Science Research Project of Hebei Education Department
- Natural Science Foundation of Hebei Province
Zitieren
APA
Guo, J., Huang, M., Hou, S., Yuan, J., Chang, X., Gao, S., Zhang, Z., Wu, Z., & Li, J. (2024). Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways. Cancer Reports, 7(9). https://doi.org/10.1002/cnr2.70006
Vancouver
Guo J, Huang M, Hou S, Yuan J, Chang X, Gao S, et al. Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways. Cancer Reports. 2024;7(9). doi:10.1002/cnr2.70006
BibTeX
@article{Guo2024,
author = {Guo, Jianxin and Huang, Ming and Hou, Shuang and Yuan, Jianfeng and Chang, Xiaoyue and Gao, Shuang and Zhang, Zhenhan and Wu, Zhongbing and Li, Jing},
title = {Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways},
journal = {Cancer Reports},
year = {2024},
volume = {7},
number = {9},
doi = {10.1002/cnr2.70006}
}
EUVIMED